BR9500539A - Composto farmacêutico e composição farmacêutica - Google Patents

Composto farmacêutico e composição farmacêutica

Info

Publication number
BR9500539A
BR9500539A BR9500539A BR9500539A BR9500539A BR 9500539 A BR9500539 A BR 9500539A BR 9500539 A BR9500539 A BR 9500539A BR 9500539 A BR9500539 A BR 9500539A BR 9500539 A BR9500539 A BR 9500539A
Authority
BR
Brazil
Prior art keywords
pharmaceutical
compound
pharmaceutical composition
composition
pharmaceutical compound
Prior art date
Application number
BR9500539A
Other languages
English (en)
Inventor
Masaaki Matsuo
Daijiro Hagiwara
Takashi Manabe
Nobukiyo Konishi
Shinji Shigenaga
Kenji Murano
Hiroshi Matsuda
Hiroshi Miyake
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9402010A external-priority patent/GB9402010D0/en
Priority claimed from GB9412708A external-priority patent/GB9412708D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR9500539A publication Critical patent/BR9500539A/pt

Links

BR9500539A 1994-02-02 1995-02-02 Composto farmacêutico e composição farmacêutica BR9500539A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9402010A GB9402010D0 (en) 1994-02-02 1994-02-02 Piperazine derivatives
GB9412708A GB9412708D0 (en) 1994-06-24 1994-06-24 Piperazine derivatives

Publications (1)

Publication Number Publication Date
BR9500539A true BR9500539A (pt) 1995-10-31

Family

ID=26304260

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9500539A BR9500539A (pt) 1994-02-02 1995-02-02 Composto farmacêutico e composição farmacêutica

Country Status (1)

Country Link
BR (1) BR9500539A (pt)

Similar Documents

Publication Publication Date Title
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
BR1100824A (pt) Composto e composição farmacêutica
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
NO20004345L (no) Farmasøytisk sammensetning
FI944832A0 (fi) Farmaseuttinen koostumus
BR9200058A (pt) Composto e composicao farmaceutica
DE69524592D1 (de) 2-Acylaminopropanolverbindung und ihre pharmazeutische Zusammensetzung
ITMI932540A0 (it) Composizione farmaceutica
BR9509688A (pt) Composto e composição farmacêutica
BR9507768A (pt) Composição farmacêutica
LV11727A (lv) Farmaceitiska kompozicija
ID18698A (id) Komposisi farmasi
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973280A0 (fi) Farmaseuttinen koostumus
LV10579A (lv) Farmaceitiska kompozicija
ITMI962628A0 (it) Composizione farmaceutica
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI962738A0 (fi) Farmaseuttiset koostumukset
BR9605777A (pt) Composição farmacêutica
BR9505130A (pt) Composto e composiçao farmacêutica
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
BR9500539A (pt) Composto farmacêutico e composição farmacêutica
BR9605131A (pt) Composição farmacêutica
BR1100838A (pt) Composto e composição farmacêutica

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]